Therapeutic strategies targeting the endothelial glycocalyx: Acute deficits, but great potential

Cardiovascular Research

Volumn 87, Issue 2, 2010, Pages 300-310

  Becker, Bernhard F ^a   Chappell, Daniel ^b   Bruegger, Dirk ^b   Annecke, Thorsten ^a,b   Jacob, Matthias ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Albumin; Hydrocortisone; Ischaemia; Lipopolysaccharide; Permeability

Indexed keywords

ANTITHROMBIN III; HYDROCORTISONE; NATRIURETIC FACTOR; OXYGEN RADICAL; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; CARDIOVASCULAR AGENT;

ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; DIABETES MELLITUS; ENZYMATIC DEGRADATION; GLYCOCALYX; HEART SURGERY; HUMAN; HYPERVOLEMIA; INFLAMMATION; INJURY; LEUKOCYTE; MAST CELL; ORGAN TRANSPLANTATION; PHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SHEAR STRESS; THROMBOCYTE; THROMBOCYTE ADHESION; VASCULAR DISEASE; ANIMAL; BODY FLUID; CAPILLARY PERMEABILITY; DRUG EFFECTS; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; BODY FLUIDS; CAPILLARY PERMEABILITY; CARDIOVASCULAR AGENTS; ENDOTHELIUM, VASCULAR; GLYCOCALYX; HUMANS;

EID: 77954325542     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq137     Document Type: Review

References (107)

1. Danielli JF. Capillary permeability and edema in the perfused frog. J Physiol (London) 1940;98:109-129.
2. Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007;9:121-167.
3. Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Arch 2000;440:653-666.
4. Baldwin AL, Winlove CP. Effects of perfusate composition on binding of ruthenium red and gold colloid to glycocalyx of rabbit aortic endothelium. J Histochem Cytochem 1984;32:259-266.
5. Brouland JP, Gilbert MA, Bonneau M, Pignaud G, Bal Dit SC, Drouet L. Macro and microheterogeneity in normal endothelial cells: differential composition of luminal glycocalyx and functional implications. Endothelium 1999;6:251-262.
6. Haldenby KA, Chappell DC, Winlove CP, Parker KH, Firth JA. Focal and regional variations in the composition of the glycocalyx of large vessel endothelium. J Vasc Res 1994;31:2-9.
7. Rostgaard J, Qvortrup K. Electron microscopic demonstrations of filamentous molecular sieve plugs in capillary fenestrae. Microvasc Res 1997;53:1-13.
8. Desjardins C, Duling BR. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol 1990;258: H647-H654.
9. Luft JH. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc 1966;25:1773-1783.
10. Loesch A, Milner P, Anglin SC, Crowe R, Miah S, McEwan JR et al. Ultrastructural localisation of nitric oxide synthase, endothelin and binding sites of lectin (from Bandeirea simplicifolia) in the rat carotid artery after balloon catheter injury. J Anat 1997;190:93-104.
11. Chappell D, Jacob M, Paul O, Rehm M, Welsch U, Stoeckelhuber M et al. The gly-cocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture. Circ Res 2009;104:1313-1317.
12. Levick JR. Revision of the Starling principle: new views of tissue fluid balance. J Physiol 2004;557:704.
13. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol 2006;176:1-40.
14. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol 2006;6: 633-643.
15. Rehm M, Haller M, Orth V, Kreimeier U, Jacob M, Dressel H et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001;95:849-856.
16. Michel CC, Curry FR. Glycocalyx volume: a critical review of tracer dilution methods for its measurement. Microcirculation 2009;16:213-219.
17. Nieuwdorp M, Meuwese MC, Mooij HL, Ince C, Broekhuizen LN, Kastelein JJ et al. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol 2008;104:845-852.
18. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007;116:1896-1906.
19. Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P et al. Antith-rombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfu-sion. Cardiovasc Res 2009;83:388-396.
20. Beresewicz A, Czarnowska E, Maczewski M. Ischemic preconditioning and superox-ide dismutase protect against endothelial dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts. Mol Cell Biochem 1998;186:87-97.
21. Mulivor AW, Lipowsky HH. Inflammation-and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 2004;286:H1672-H1680.
22. Rubio-Gayosso I, Platts SH, Duling BR. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006;290:H2247-H2256.
23. Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000;279:H2815-H2823.
24. Chappell D, Jacob M, Rehm M, Stoeckelhuber M, Welsch U, Conzen P et al. Hepar-inase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem 2008;389:79-82.
25. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES. The Endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 2005;16:507-511.
26. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008;109:723-740.
27. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol 1896;19:312-326.
28. Levick JR, Smaje LH. An analysis of the permeability of a fenestra. Microvasc Res 1987; 33:233-256.
29. Curry FE, Michel CC. A fiber matrix model of capillary permeability. Microvasc Res 1980;20:96-99.
30. Noble LJ, Mautes AE, Hall JJ. Characterization of the microvascular glycocalyx in normal and injured spinal cord in the rat. J Comp Neurol 1996;376:542-556.
31. Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M et al. Endothelial glyco-calyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004;100: 1211-1223.
32. Jeansson M, Haraldsson B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 2006;290:F111-F116.
33. Salmon AH, Neal CR, Sage LM, Glass CA, Harper SJ, Bates DO. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res 2009;83:24-33.
34. Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE. Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 2004;557:889-907.
35. Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006;104:1223-1231.
36. Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P et al. The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007;73:575-586.
37. Curry FR. Microvascular solute and water transport. Microcirculation 2005;12:17-31.
38. Florian JA, Kosky JR, Ainslie K, Pang Z, Dull RO, Tarbell JM. Heparan sulfate proteo-glycan is a mechanosensor on endothelial cells. Circ Res 2003;93:e136-e142.
39. Chang YS, Yaccino JA, Lakshminarayanan S, Frangos JA, Tarbell JM. Shear-induced increase in hydraulic conductivity in endothelial cells is mediated by a nitric oxide-dependent mechanism. Arterioscler Thromb Vasc Biol 2000;20:35-42.
40. Kuchan MJ, Frangos JA. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 1994;266:C628-C636.
41. Jacob M, Rehm M, Loetsch M, Paul JO, Bruegger D, Welsch U et al. The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J Vasc Res 2007;44:435-443.
42. Marten K, Schmiedl A, Schnabel PA, Richter J. Structural protection of the myocar-dial capillary endothelium by different forms of cardiac arrest and subsequent global ischemia at 5 degrees C. Thorac Cardiovasc Surg 1999;47:205-212.
43. Seal JB, Gewertz BL. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 2005;19:572-584.
44. Tarbell JM, Pahakis MY. Mechanotransduction and the glycocalyx. J Intern Med 2006; 259:339-350.
45. Broekhuizen LN, Mooij HL, Kastelein JJ, Stroes ES, Vink H, Nieuwdorp M. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Curr Opin Lipidol 2009;20:57-62.
46. Chappell D, Jacob M, Becker BF, Hofmann-Kiefer K, Conzen P, Rehm M. Expedition glycocalyx. A newly discovered 'Great Barrier Reef'. Anaesthesist 2008;57:959-969.
47. Barajas-Espinosa A, Ramiro-Diaz J, Briones-Cerecero E, Chi-Ahumada E, De la Rosa AB, Arroyo-Flores B et al. Involvement of endothelial Man and Gal-binding lectins in sensing the flow in coronary arteries. Front Biosci 2008;13:5421-5431.
48. Vink H, Constantinescu AA, Spaan JA. Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 2000;101: 1500-1502.
49. Mulivor AW, Lipowsky HH. Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrixmetalloprotease activity with doxycycline. Microcirculation 2009;16:657-666.
50. Becker BF, Zahler S, Kupatt C, Seligmann C, Heindl B, Kowalski C. Cardiovascular actions of adenosine. Granulocyte and blood platelet adhesion in the reperfused myocardium. Adv Exp Med Biol 1998;431:73-78.
51. Heindl B, Zahler S, Welsch U, Becker BF. Disparate effects of adhesion and degra-nulation of platelets on myocardial and coronary function in postischaemic hearts. Cardiovasc Res 1998;38:383-394.
52. Bruegger D, Rehm M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U et al. Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts. Crit Care 2008;12:R73.
53. Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glyco-calyx. Anesthesiology 2007;107:776-784.
54. Kharabi MB, Ten Dam GB, Wild MK, Seelige R, van der Vlag J, Rops AL et al. Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensi-tivity. J Immunol 2009;182:4985-4993.
55. Nieuwdorp M, Meuwese MC, Mooij HL, van Lieshout MH, Hayden A, Levi M et al. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced Endothelial glycocalyx perturbation. Atherosclerosis 2009;202:296-303.
56. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999;68:729-777.
57. VanTeeffelen JW, Dekker S, Fokkema DS, Siebes M, Vink H, Spaan JA. Hyaluronidase treatment of coronary glycocalyx increases reactive hyperemia but not adenosine hyperemia in dog hearts. Am J Physiol Heart Circ Physiol 2005;289:H2508-H2513.
58. Henry CB, Duling BR. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 1999;277:H508-H514.
59. Ward BJ, Donnelly JL. Hypoxia induced disruption of the cardiac endothelial glyco-calyx: implications for capillary permeability. Cardiovasc Res 1993;27:384-389.
60. Habazettl H, Kupatt C, Zahler S, Becker BF, Messmer K. Selectins and beta 2-integrins mediate post-ischaemic venular adhesion of polymorphonuclear leukocytes, but not capillary plugging, in isolated hearts. Pflugers Arch 1999;438:479-485.
61. Bruegger D, Rehm M, Abicht J, Paul JO, Stoeckelhuber M, Pfirrmann M et al. Shedding of the endothelial glycocalyx during cardiac surgery: on-pump versus off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2009;138:1445-1447.
62. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34:17-60.
63. Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol 2009;22:155-162.
64. Schouten M, Wiersinga WJ, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008;83:536-545.
65. Becker BF, Heindl B, Kupatt C, Zahler S. Endothelial function and hemostasis. Z Kardiol 2000;89:160-167.
66. Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocor-tisone and antithrombin. Basic Res Cardiol 2009;104:78-89.
67. Marechal X, Favory R, Joulin O, Montaigne D, Hassoun S, Decoster B et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008;29:572-576.
68. Pejler G, Abrink M, Ringvall M, Wernersson S. Mast cell proteases. Adv Immunol 2007;95:167-255.
69. Reil JC, Gilles S, Zahler S, Brandl A, Drexler H, Hultner L et al. Insights from knockout models concerning postischemic release of TNFalpha from isolated mouse hearts. J Mol Cell Cardiol 2007;42:133-1341.
70. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M. Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008;30:623-627.
71. van den Berg BM, Spaan JA, Rolf TM, Vink H. Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation. Am J Physiol Heart Circ Physiol 2006;290:H915-H920.
72. Meuwese MC, Mooij HL, Nieuwdorp M, van Lith B, Marck R, Vink H et al. Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia. J Lipid Res 2009;50:148-153.
73. Algenstaedt P, Schaefer C, Biermann T, Hamann A, Schwarzloh B, Greten H et al. Microvascular alterations in diabetic mice correlate with level of hyperglycemia. Diabetes 2003;52:542-549.
74. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
75. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006;55: 480-486.
76. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006;55:1127-1132.
77. Jacob M, Chappell D, Rehm M. The 'third space'\fact or fiction? Best Pract Res Clin Anaesthesiol 2009;23:145-157.
78. Jacob M, Chappell D, Rehm M. Clinical update: perioperative fluid management. Lancet 2007;369:1984-1986.
79. Curry FR. Atrial natriuretic peptide: an essential physiological regulator of transvas-cular fluid, protein transport, and plasma volume. J Clin Invest 2005;115:1458-1461.
80. Tucker VL. Plasma ANP levels and protein extravasation during graded expansion with equilibrated whole blood. Am J Physiol 1996;271:R601-R609.
81. Bruegger D, Jacob M, Rehm M, Loetsch M, Welsch U, Conzen P et al. Atrial natriure-tic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol 2005;289:H1993-H1999.
82. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992;86:1081-1088.
83. Chappell D, Jacob M, Paul O, Mehringer L, Newman W, Becker BF. Impaired glyco-calyx barrier properties and increased capillary tube haematocrit. J Physiol 2008;586: 4585-4586.
84. Potter DR, Jiang J, Damiano ER. The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circ Res 2009;104:1318-1325.
85. Raschke P, Becker BF. Adenosine and PAF-dependent mechanisms lead to myocar-dial reperfusion injury by neutrophils after brief ischemia. Cardiovasc Res 1995;29: 569-576.
86. Zahler S, Heindl B, Becker BF. Selectin-mediated rolling of neutrophils is essential for their activation and retention in the reperfused coronary system. Basic Res Cardiol 2002;97:359-364.
87. Kupatt C, Habazettl H, Zahler S, Weber C, Becker BF, Messmer K et al. ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury. Cardiovasc Res 1997;36:386-395.
88. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth Official Adult Heart Transplant Report-2007. J Heart Lung Transplant 2007;26:769-781. (Pubitemid 47199081)
89. Jacob M, Paul O, Mehringer L, Chappell D, Rehm M, Welsch U et al. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009;87:956-965.
90. Annane D. Glucocorticoids in the treatment of severe sepsis and septic shock. Curr Opin Crit Care 2005;11:449-453.
91. Mukaida N, Zachariae CC, Gusella GL, Matsushima K. Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor. J Immunol 1991;146:1212-1215.
92. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8:473-479.
93. Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2004;2: 1-12.
94. Kilger E, Weis F, Briegel J, Frey L, Goetz AE, Reuter D et al. Stress doses of hydro-cortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003;31:1068-1074.
95. Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and-4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 1997; 272:14713-14720.
96. Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 2002;111:635-646.
97. Afshari A, Wetterslev J, Brok J, Moller AM. Antithrombin III for critically ill patients. Cochrane Database Syst Rev 2008;3:CD005370.
98. Mizutani A, Okajima K, Uchiba M, Isobe H, Harada N, Mizutani S et al. Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 2003;101:3029-3036.
99. Kaneider NC, Forster E, Mosheimer B, Sturn DH, Wiedermann CJ. Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin. Thromb Haemost 2003;90:1150-1157.
100. Dickneite G, Leithauser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol 1999;19:1566-1572.
101. Czarnowska E, Karwatowska-Prokopczuk E. Ultrastructural demonstration of Endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Res Cardiol 1995;90:357-364.
102. Brandstrup B. Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol 2006;20:265-283.
103. Potter DR, Damiano ER. The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ Res 2008;102:770-776.
104. Gotte M. Syndecans in inflammation. FASEB J 2003;17:575-591.
105. Vanhoutte D, Schellings MW, Gotte M, Swinnen M, Herias V, Wild MK et al. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation 2007;115:475-482.
106. Floer M, Goette M, Wild MK, Heidemann J, Gassar ES, Domschke W et al. Enoxa-parin improves the course of dextran sodium sulfate colitis in syndecan-1 deficient mice. Am J Pathol 2010;176:146-157.
107. Annecke T, Chappell D, Chen C, Jacob M, Welsch U, Sommerhoff CP et al. Sevo-flurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. Br J Anaesth 2010;104:414-421.